Showing results (461-470 of 534) with videos related to

Sort By:
Pageof 54
Journal of Clinical Immunology|September 12, 2024
Hyperferritinemia Screening to Aid Identification and Differentiation of Patients with Hyperinflammatory DisordersHallie A Carol, Adam S Mayer, Michael S Zhang, et al.
Leukemia & Lymphoma|September 17, 2014
Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplantParastoo B Dahi, Miguel A Perales, Sean M Devlin, et al.
Bone Marrow Transplantation|May 12, 2020
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplantVanessa A Fabrizio, Nancy A Kernan, Farid Boulad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 8, 2013
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remissionUlas D Bayraktar, Marcos de Lima, Rima M Saliba, et al.
Blood Advances|March 29, 2019
Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysisJuliet N Barker, Kirsten Boughan, Parastoo B Dahi, et al.
Contraception|October 3, 2024
Comparison of etonogestrel bioanalytical assay results in plasma and serum within and across laboratoriesShawnalyn W Sunagawa, Lee C Winchester, Christopher S Wichman, et al.
Developmental Cell|July 13, 2021
FANCI functions as a repair/apoptosis switch in response to DNA crosslinksRicha B Shah, Jennifer L Kernan, Anya van Hoogstraten, et al.
Research Square|July 9, 2024
Hyperferritinemia screening to aid identification and differentiation of patients with hyperinflammatory disordersHallie A Carol, Adam S Mayer, Michael S Zhang, et al.
Bone Marrow Transplantation|September 29, 2023
T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AMLAlexandra M Satty, Elizabeth Klein, Audrey Mauguen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failureJoseph H Chewning, Hugo Castro-Malaspina, Ann Jakubowski, et al.
Pageof 54